{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:10:11Z","timestamp":1758885011533,"version":"3.44.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["YSS\/2014\/000139","YSS\/2015\/000025"],"award-info":[{"award-number":["YSS\/2014\/000139","YSS\/2015\/000025"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR22434\/MED\/30\/1901\/2017","BT\/PR22434\/MED\/30\/1901\/2017"],"award-info":[{"award-number":["BT\/PR22434\/MED\/30\/1901\/2017","BT\/PR22434\/MED\/30\/1901\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mammary Gland Biol Neoplasia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10911-025-09585-5","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:45:45Z","timestamp":1758883545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does microtubule motor-mediated centrosomal dyshomeostasis confer chemoresistance in breast cancer?"],"prefix":"10.1007","volume":"30","author":[{"given":"J.","family":"Priyanga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunjan","family":"Guha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipita","family":"Bhakta-Guha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"9585_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F, Global Cancer Statistics 2020. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA. Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Cancer J Clin"},{"key":"9585_CR2","doi-asserted-by":"publisher","first-page":"e885","DOI":"10.1016\/S2214-109X(18)30257-2","volume":"6","author":"JK Birnbaum","year":"2018","unstructured":"Birnbaum JK, Duggan C, Anderson BO, Etzioni R. Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study. Lancet Glob Health. 2018;6:e885\u201393. https:\/\/doi.org\/10.1016\/S2214-109X(18)30257-2.","journal-title":"Lancet Glob Health"},{"key":"9585_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast Cancer treatment: A review. JAMA. 2019;321:288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323.","journal-title":"JAMA"},{"key":"9585_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1470-2045(10)70025-5","volume":"11","author":"H Wildiers","year":"2010","unstructured":"Wildiers H, Forceville K, Paridaens R, Joensuu H. Taxanes and anthracyclines in early breast cancer: which first? Lancet Oncol. 2010;11:219\u201320. https:\/\/doi.org\/10.1016\/S1470-2045(10)70025-5.","journal-title":"Lancet Oncol"},{"key":"9585_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12609-012-0097-1","volume":"5","author":"E Andreopoulou","year":"2013","unstructured":"Andreopoulou E, Sparano JA. Chemotherapy in patients with anthracycline- and Taxane-Pretreated metastatic breast cancer: an overview, curr. Breast Cancer Rep. 2013;5:42\u201350. https:\/\/doi.org\/10.1007\/s12609-012-0097-1.","journal-title":"Breast Cancer Rep"},{"key":"9585_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3816\/CBC.2000.n.002","volume":"1","author":"JA Sparano","year":"2000","unstructured":"Sparano JA. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials. Clin Breast Cancer. 2000;1:32\u201340. https:\/\/doi.org\/10.3816\/CBC.2000.n.002. discussion 41\u201342.","journal-title":"Clin Breast Cancer"},{"key":"9585_CR7","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1634\/theoncologist.2017-0672","volume":"23","author":"AN Shah","year":"2018","unstructured":"Shah AN, Gradishar WJ. Adjuvant anthracyclines in breast cancer: what is their role?? Oncologist. 2018;23:1153\u201361. https:\/\/doi.org\/10.1634\/theoncologist.2017-0672.","journal-title":"Oncologist"},{"key":"9585_CR8","doi-asserted-by":"publisher","first-page":"108800","DOI":"10.1016\/j.biopha.2019.108800","volume":"114","author":"X Ji","year":"2019","unstructured":"Ji X, Lu Y, Tian H, Meng X, Wei M, Cho WC. Chemoresistance mechanisms of breast cancer and their countermeasures. Biomed Pharmacother. 2019;114:108800. https:\/\/doi.org\/10.1016\/j.biopha.2019.108800.","journal-title":"Biomed Pharmacother"},{"key":"9585_CR9","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3389\/fonc.2021.658552","volume":"11","author":"J Cao","year":"2021","unstructured":"Cao J, Zhang M, Wang B, Zhang L, Zhou F, Fang M. Chemoresistance and metastasis in breast Cancer molecular mechanisms and novel clinical strategies. Front Oncol. 2021;11:1701. https:\/\/doi.org\/10.3389\/fonc.2021.658552.","journal-title":"Front Oncol"},{"key":"9585_CR10","unstructured":"United Nations, THE 17 GOALS | Sustainable Development. 2025. https:\/\/sdgs.un.org\/goals.\u00a0Accessed May 20, 2025."},{"key":"9585_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"B Mansoori","year":"2017","unstructured":"Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of Cancer drug resistance: A brief review. Adv Pharm Bull. 2017;7:339\u201348. https:\/\/doi.org\/10.15171\/apb.2017.041.","journal-title":"Adv Pharm Bull"},{"key":"9585_CR12","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.3390\/ijms22179451","volume":"22","author":"A Ramos","year":"2021","unstructured":"Ramos A, Sadeghi S, Tabatabaeian H. Battling chemoresistance in cancer: root causes and strategies to uproot them. Int J Mol Sci. 2021;22:9451. https:\/\/doi.org\/10.3390\/ijms22179451.","journal-title":"Int J Mol Sci"},{"key":"9585_CR13","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/bjc.2011.130","volume":"104","author":"J Li","year":"2011","unstructured":"Li J, Zhan Q. The role of centrosomal Nlp in the control of mitotic progression and tumourigenesis. Br J Cancer. 2011;104:1523\u20138. https:\/\/doi.org\/10.1038\/bjc.2011.130.","journal-title":"Br J Cancer"},{"key":"9585_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4161\/cbt.13.3.18697","volume":"13","author":"W Zhao","year":"2012","unstructured":"Zhao W, Song Y, Xu B, Zhan Q. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to Paclitaxel. Cancer Biol Ther. 2012;13:156\u201363. https:\/\/doi.org\/10.4161\/cbt.13.3.18697.","journal-title":"Cancer Biol Ther"},{"key":"9585_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2741\/4212","volume":"19","author":"M Marina","year":"2014","unstructured":"Marina M, Saavedra HI. Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance. Front Biosci Landmark Ed. 2014;19:352\u201365. https:\/\/doi.org\/10.2741\/4212.","journal-title":"Front Biosci Landmark Ed"},{"key":"9585_CR16","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00418-008-0427-6","volume":"129","author":"H Schatten","year":"2008","unstructured":"Schatten H. The mammalian centrosome and its functional significance. Histochem Cell Biol. 2008;129:667\u201386. https:\/\/doi.org\/10.1007\/s00418-008-0427-6.","journal-title":"Histochem Cell Biol"},{"key":"9585_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1741-7007-11-28","volume":"11","author":"M Bettencourt-Dias","year":"2013","unstructured":"Bettencourt-Dias M, Q&A. Who needs a centrosome? BMC Biol. 2013;11:28. https:\/\/doi.org\/10.1186\/1741-7007-11-28.","journal-title":"BMC Biol"},{"key":"9585_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.semcdb.2020.06.018","volume":"107","author":"E Nazockdast","year":"2020","unstructured":"Nazockdast E, Redemann S. Mechanics of the spindle apparatus, Semin. Cell Dev Biol. 2020;107:91\u2013102. https:\/\/doi.org\/10.1016\/j.semcdb.2020.06.018.","journal-title":"Cell Dev Biol"},{"key":"9585_CR19","doi-asserted-by":"publisher","unstructured":"Wu Q, Li B, Liu L, Sun S, Sun S. Centrosome dysfunction: a link between senescence and tumor immunity, signal transduct. Target Ther. 2020;5. https:\/\/doi.org\/10.1038\/s41392-020-00214-7.","DOI":"10.1038\/s41392-020-00214-7"},{"key":"9585_CR20","doi-asserted-by":"publisher","unstructured":"Fu J, Hagan IM, Glover DM. The centrosome and its duplication cycle, cold spring Harb. Perspect Biol. 2015;7. https:\/\/doi.org\/10.1101\/cshperspect.a015800.","DOI":"10.1101\/cshperspect.a015800"},{"key":"9585_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/sj.leu.2402454","volume":"16","author":"A Kr\u00e4mer","year":"2002","unstructured":"Kr\u00e4mer A, Neben K, Ho AD. Centrosome replication, genomic instability and cancer. Leukemia. 2002;16:767\u201375. https:\/\/doi.org\/10.1038\/sj.leu.2402454.","journal-title":"Leukemia"},{"key":"9585_CR22","doi-asserted-by":"publisher","unstructured":"Jusino S, Fern\u00e1ndez-Pad\u00edn FM, Saavedra HI. Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity. J Cancer Metastasis Treat. 2018;4. https:\/\/doi.org\/10.20517\/2394-4722.2018.24.","DOI":"10.20517\/2394-4722.2018.24"},{"key":"9585_CR23","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1073\/pnas.95.6.2950","volume":"95","author":"WL Lingle","year":"1998","unstructured":"Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell Polarity. Proc Natl Acad Sci. 1998;95:2950\u20135. https:\/\/doi.org\/10.1073\/pnas.95.6.2950.","journal-title":"Proc Natl Acad Sci"},{"key":"9585_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2174\/0929867322666141212114529","volume":"22","author":"D Bhakta-Guha","year":"2015","unstructured":"Bhakta-Guha D, Saeed MEM, Greten HJ, Efferth T. Dis-organizing centrosomal clusters: specific cancer therapy for a generic spread? Curr Med Chem. 2015;22:685\u201394. https:\/\/doi.org\/10.2174\/0929867322666141212114529.","journal-title":"Curr Med Chem"},{"key":"9585_CR25","doi-asserted-by":"publisher","first-page":"T47","DOI":"10.1530\/ERC-17-0072","volume":"24","author":"A Ogden","year":"2017","unstructured":"Ogden A, Rida PCG, Aneja R. Centrosome amplification: a suspect in breast cancer and Racial disparities. Endocr Relat Cancer. 2017;24:T47\u201364. https:\/\/doi.org\/10.1530\/ERC-17-0072.","journal-title":"Endocr Relat Cancer"},{"key":"9585_CR26","doi-asserted-by":"publisher","first-page":"188524","DOI":"10.1016\/j.bbcan.2021.188524","volume":"1875","author":"J Priyanga","year":"2021","unstructured":"Priyanga J, Guha G, Bhakta-Guha D. Microtubule motors in centrosome homeostasis: A target for cancer therapy? Biochim Biophys Acta Rev Cancer. 2021;1875:188524. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188524.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"9585_CR27","unstructured":"Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P, Motors M. Mol. Biol. Cell 4th Ed. 2002. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26888\/.\u00a0Accessed 22 Apr 2020."},{"key":"9585_CR28","unstructured":"Cooper GM. Microtubule Motors and Movements, Cell Mol. Approach 2nd Ed. 2000. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK9833\/. Accessed 22 Apr 2020."},{"key":"9585_CR29","unstructured":"Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. Kinesin, Dynein, and Intracellular Transport, in: Mol. Cell Biol., 4th ed., W. H. Freeman, 2000. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK21710\/.\u00a0Accessed 20 Apr 2020."},{"key":"9585_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.tcb.2013.06.003","volume":"23","author":"R Mallik","year":"2013","unstructured":"Mallik R, Rai AK, Barak P, Rai A, Kunwar A. Teamwork in microtubule motors. Trends Cell Biol. 2013;23:575\u201382. https:\/\/doi.org\/10.1016\/j.tcb.2013.06.003.","journal-title":"Trends Cell Biol"},{"key":"9585_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2021.8072","volume":"46","author":"D Huo","year":"2021","unstructured":"Huo D, Yang H, Huang J-D, Cai J-P, Cui J. Roles of Kinesin superfamily proteins in colorectal cancer carcinogenesis (Review). Oncol Rep. 2021;46:1\u201310. https:\/\/doi.org\/10.3892\/or.2021.8072.","journal-title":"Oncol Rep"},{"key":"9585_CR32","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.3390\/cancers15133308","volume":"15","author":"Q-H Chen","year":"2023","unstructured":"Chen Q-H. Crosstalk between microtubule stabilizing agents and prostate Cancer. Cancers. 2023;15:3308. https:\/\/doi.org\/10.3390\/cancers15133308.","journal-title":"Cancers"},{"key":"9585_CR33","doi-asserted-by":"publisher","unstructured":"Liu X, Lin Y, Long W, Yi R, Zhang X, Xie C, Jin N, Qiu Z, Liu X. The kinesin-14 family motor protein KIFC2 promotes prostate cancer progression by regulating p65. J Biol Chem. 2023;299. https:\/\/doi.org\/10.1016\/j.jbc.2023.105253.","DOI":"10.1016\/j.jbc.2023.105253"},{"key":"9585_CR34","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1631\/jzus.B1700129","volume":"18","author":"L Pan","year":"2017","unstructured":"Pan L, Zhang Y, Zhu C, Dong Z. Kinesin KIF4A is associated with chemotherapeutic drug resistance by regulating intracellular trafficking of lung resistance-related protein. J Zhejiang Univ Sci B. 2017;18:1046\u201354. https:\/\/doi.org\/10.1631\/jzus.B1700129.","journal-title":"J Zhejiang Univ Sci B"},{"key":"9585_CR35","doi-asserted-by":"publisher","first-page":"105017","DOI":"10.1016\/j.jddst.2023.105017","volume":"89","author":"MN Yukuyama","year":"2023","unstructured":"Yukuyama MN, de Souza A, Henostroza MAB, de Araujo GLB, L\u00f6benberg R, de Faria R, de Souza GB, Guimaraes LMF, Lameu C, Folchini BR, Peroni CM, Oliveira IF, Miyagi MYS. Bou-Chacra, unveiling microtubule dynamics in lung cancer: recent findings and prospects for drug delivery and treatment. J Drug Deliv Sci Technol. 2023;89:105017. https:\/\/doi.org\/10.1016\/j.jddst.2023.105017.","journal-title":"J Drug Deliv Sci Technol"},{"key":"9585_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40364-024-00559-z","volume":"12","author":"K Zhao","year":"2024","unstructured":"Zhao K, Li X, Feng Y, Wang J, Yao W. The role of Kinesin family members in hepatobiliary carcinomas: from bench to bedside. Biomark Res. 2024;12:30. https:\/\/doi.org\/10.1186\/s40364-024-00559-z.","journal-title":"Biomark Res"},{"key":"9585_CR37","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.1158\/0008-5472.CAN-09-1224","volume":"69","author":"S De","year":"2009","unstructured":"De S, Cipriano R, Jackson MW, Stark GR. Overexpression of kinesins mediates docetaxel resistance in breast Cancer cells. Cancer Res. 2009;69:8035\u201342.","journal-title":"Cancer Res"},{"key":"9585_CR38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10549-011-1500-8","volume":"131","author":"MH Tan","year":"2012","unstructured":"Tan MH, De S, Bebek G, Orloff MS, Wesolowski R, Downs-Kelly E, Budd GT, Stark GR, Eng C. Specific Kinesin expression profiles associated with taxane resistance in basal-like breast cancer. Breast Cancer Res Treat. 2012;131:849\u201358. https:\/\/doi.org\/10.1007\/s10549-011-1500-8.","journal-title":"Breast Cancer Res Treat"},{"key":"9585_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neo.2014.03.008","volume":"16","author":"SM Singel","year":"2014","unstructured":"Singel SM, Cornelius C, Zaganjor E, Batten K, Sarode VR, Buckley DL, Peng Y, John GB, Li HC, Sadeghi N, Wright WE, Lum L, Corson TW, Shay JW. KIF14 promotes AKT phosphorylation and contributes to chemoresistance in Triple-Negative breast cancer, neoplasia N. Y N. 2014;16:247\u2013e2562. https:\/\/doi.org\/10.1016\/j.neo.2014.03.008.","journal-title":"Y N"},{"key":"9585_CR40","doi-asserted-by":"publisher","unstructured":"Agircan FG, Schiebel E, Mardin BR. Separate to operate: control of centrosome positioning and separation. Philos Trans R Soc B Biol Sci. 2014;369. https:\/\/doi.org\/10.1098\/rstb.2013.0461.","DOI":"10.1098\/rstb.2013.0461"},{"key":"9585_CR41","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41556-019-0385-3","volume":"21","author":"CG Morrison","year":"2019","unstructured":"Morrison CG. KIFC3 directs a centrosome cohesive force. Nat Cell Biol. 2019;21:1057\u20139. https:\/\/doi.org\/10.1038\/s41556-019-0385-3.","journal-title":"Nat Cell Biol"},{"key":"9585_CR42","doi-asserted-by":"publisher","first-page":"144989","DOI":"10.1016\/j.gene.2020.144989","volume":"760","author":"A Parvin","year":"2020","unstructured":"Parvin A, Hao S-L, Tan F-Q, Yang W-X. Inhibition of Kinesin motor protein KIFC1 by AZ82 induces multipolar mitosis and apoptosis in prostate cancer cell. Gene. 2020;760:144989. https:\/\/doi.org\/10.1016\/j.gene.2020.144989.","journal-title":"Gene"},{"key":"9585_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41467-020-20208-x","volume":"12","author":"G Fan","year":"2021","unstructured":"Fan G, Sun L, Meng L, Hu C, Wang X, Shi Z, Hu C, Han Y, Yang Q, Cao L, Zhang X, Zhang Y, Song X, Xia S, He B, Zhang S, Wang C. The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation. Nat Commun. 2021;12:20. https:\/\/doi.org\/10.1038\/s41467-020-20208-x.","journal-title":"Nat Commun"},{"key":"9585_CR44","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"9585_CR45","unstructured":"PRISMA, flow chart PRISMA. 2021. http:\/\/prisma-statement.org\/prismastatement\/flowdiagram.aspx. Accessed 23 Nov 2021."},{"key":"9585_CR46","doi-asserted-by":"publisher","first-page":"16416","DOI":"10.1074\/jbc.M802360200","volume":"283","author":"W Zhang","year":"2008","unstructured":"Zhang W, Cheng GZ, Gong J, Hermanto U, Zong CS, Chan J, Cheng JQ, Wang L-H. RACK1 and CIS mediate the degradation of BimEL in Cancer cells. J Biol Chem. 2008;283:16416\u201326. https:\/\/doi.org\/10.1074\/jbc.M802360200.","journal-title":"J Biol Chem"},{"key":"9585_CR47","doi-asserted-by":"publisher","first-page":"23691","DOI":"10.1073\/pnas.1910824116","volume":"116","author":"S Rodrigues-Ferreira","year":"2019","unstructured":"Rodrigues-Ferreira S, Nehlig A, Moindjie H, Monchecourt C, Seiler C, Marangoni E, Chateau-Joubert S, Dujaric M-E, Servant N, Asselain B, de Cremoux P, Lacroix-Triki M, Arnedos M, Pierga J-Y, Andr\u00e9 F, Nahmias C. Improving breast cancer sensitivity to Paclitaxel by increasing aneuploidy. Proc Natl Acad Sci. 2019;116:23691\u20137. https:\/\/doi.org\/10.1073\/pnas.1910824116.","journal-title":"Proc Natl Acad Sci"},{"key":"9585_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0147-0272(92)90002-6","volume":"16","author":"VC Jordan","year":"1992","unstructured":"Jordan VC. The role of Tamoxifen in the treatment and prevention of breast cancer. Curr Probl Cancer. 1992;16:129\u201376. https:\/\/doi.org\/10.1016\/0147-0272(92)90002-6.","journal-title":"Curr Probl Cancer"},{"key":"9585_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/clpt.2012.94","volume":"92","author":"L Binkhorst","year":"2012","unstructured":"Binkhorst L, van Gelder T, Mathijssen RHJ. Individualization of Tamoxifen treatment for breast carcinoma. Clin Pharmacol Ther. 2012;92:431\u20133. https:\/\/doi.org\/10.1038\/clpt.2012.94.","journal-title":"Clin Pharmacol Ther"},{"key":"9585_CR50","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.1038\/s41598-018-27810-6","volume":"8","author":"R Han","year":"2018","unstructured":"Han R, Gu S, Zhang Y, Luo A, Jing X, Zhao L, Zhao X, Zhang L. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of twist via PI3K\/AKT\/NF-\u03baB signaling. Sci Rep. 2018;8:9575. https:\/\/doi.org\/10.1038\/s41598-018-27810-6.","journal-title":"Sci Rep"},{"key":"9585_CR51","unstructured":"Farrar MC, Jacobs TF. Tamoxifen, in: StatPearls, StatPearls Publishing, Treasure Island (FL), 2021. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532905\/.\u00a0Accessed 12 Nov 2021."},{"key":"9585_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.6026\/97320630012135","volume":"12","author":"S Ali","year":"2016","unstructured":"Ali S, Rasool M, Chaoudhry H, Pushparaj PN, Jha P, Hafiz A, Mahfooz M, Abdus Sami G, Azhar Kamal M, Bashir S, Ali A. Sarwar jamal, molecular mechanisms and mode of Tamoxifen resistance in breast cancer. Bioinformation. 2016;12:135\u20139. https:\/\/doi.org\/10.6026\/97320630012135.","journal-title":"Bioinformation"},{"key":"9585_CR53","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1158\/1541-7786.MCR-13-0459","volume":"12","author":"JX Zou","year":"2014","unstructured":"Zou JX, Duan Z, Wang J, Sokolov A, Xu J, Chen CZ, Li JJ, Chen H-W. Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and Tamoxifen resistance. Mol Cancer Res MCR. 2014;12:539\u201349. https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0459.","journal-title":"Mol Cancer Res MCR"},{"key":"9585_CR54","doi-asserted-by":"publisher","first-page":"18067","DOI":"10.1073\/pnas.0705814104","volume":"104","author":"JX Zou","year":"2007","unstructured":"Zou JX, Revenko AS, Li LB, Gemo AT, Chen H-W. ANCCA, an estrogen-regulated AAA\u2009+\u2009ATPase coactivator for ER\u03b1, is required for coregulator occupancy and chromatin modification. Proc Natl Acad Sci. 2007;104:18067\u201372. https:\/\/doi.org\/10.1073\/pnas.0705814104.","journal-title":"Proc Natl Acad Sci"},{"key":"9585_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10549-018-4978-5","volume":"173","author":"LH Alfarsi","year":"2019","unstructured":"Alfarsi LH, Elansari R, Toss MS, Diez-Rodriguez M, Nolan CC, Ellis IO, Rakha EA, Green AR. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER\u2009+\u2009breast cancer. Breast Cancer Res Treat. 2019;173:93\u2013102. https:\/\/doi.org\/10.1007\/s10549-018-4978-5.","journal-title":"Breast Cancer Res Treat"},{"key":"9585_CR56","unstructured":"Johnson-Arbor K, Dubey R. Doxorubicin, in: StatPearls, StatPearls Publishing, Treasure Island (FL), 2021. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459232\/. Accessed 13 Nov 2021."},{"key":"9585_CR57","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/s12885-019-5939-z","volume":"19","author":"C Christowitz","year":"2019","unstructured":"Christowitz C, Davis T, Isaacs A, van Niekerk G, Hattingh S, Engelbrecht A-M. Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model. BMC Cancer. 2019;19:757. https:\/\/doi.org\/10.1186\/s12885-019-5939-z.","journal-title":"BMC Cancer"},{"key":"9585_CR58","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/cas.14324","volume":"111","author":"W Wang","year":"2020","unstructured":"Wang W, Zhang R, Wang X, Wang N, Zhao J, Wei Z, Xiang F, Wang C. Suppression of KIF3A inhibits triple negative breast cancer growth and metastasis by repressing Rb-E2F signaling and epithelial\u2010mesenchymal transition. Cancer Sci. 2020;111:1422\u201334. https:\/\/doi.org\/10.1111\/cas.14324.","journal-title":"Cancer Sci"},{"key":"9585_CR59","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12935-021-02235-w","volume":"21","author":"C-F Jiang","year":"2021","unstructured":"Jiang C-F, Xie Y-X, Qian Y-C, Wang M, Liu L-Z, Shu Y-Q, Bai X-M, Jiang B-H. TBX15\/miR-152\/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination. Cancer Cell Int. 2021;21:542. https:\/\/doi.org\/10.1186\/s12935-021-02235-w.","journal-title":"Cancer Cell Int"},{"key":"9585_CR60","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","volume":"4","author":"MA Jordan","year":"2004","unstructured":"Jordan MA, Wilson. Microtubules as a target for anticancer drugs. Nat Rev Cancer. 2004;4:253\u201365. https:\/\/doi.org\/10.1038\/nrc1317.","journal-title":"Nat Rev Cancer"},{"key":"9585_CR61","doi-asserted-by":"publisher","first-page":"E3323","DOI":"10.3390\/cancers12113323","volume":"12","author":"SM Maloney","year":"2020","unstructured":"Maloney SM, Hoover CA, Morejon-Lasso LV, Prosperi JR. Mechanisms of taxane resistance. Cancers. 2020;12:E3323. https:\/\/doi.org\/10.3390\/cancers12113323.","journal-title":"Cancers"},{"key":"9585_CR62","first-page":"106","volume":"12","author":"HA Wahba","year":"2015","unstructured":"Wahba HA, El-Hadaad HA. Current approaches in treatment of triple-negative breast cancer. Cancer Biol Med. 2015;12:106\u201316.","journal-title":"Cancer Biol Med"},{"key":"9585_CR63","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.2147\/DDDT.S86105","volume":"9","author":"G Mustacchi","year":"2015","unstructured":"Mustacchi G, De Laurentiis M. The role of taxanes in triple-negative breast cancer: literature review. Drug Des Devel Ther. 2015;9:4303\u201318. https:\/\/doi.org\/10.2147\/DDDT.S86105.","journal-title":"Drug Des Devel Ther"},{"key":"9585_CR64","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1038\/sj.onc.1206934","volume":"22","author":"GA Orr","year":"2003","unstructured":"Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB. Mechanisms of taxol resistance related to microtubules. Oncogene. 2003;22:7280\u201395. https:\/\/doi.org\/10.1038\/sj.onc.1206934.","journal-title":"Oncogene"},{"key":"9585_CR65","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1002\/pmic.201000789","volume":"11","author":"L Froidevaux-Klipfel","year":"2011","unstructured":"Froidevaux-Klipfel L, Poirier F, Boursier C, Cr\u00e9pin R, Po\u00fcs C, Baudin B, Baillet A. Modulation of Septin and molecular motor recruitment in the microtubule environment of the Taxol-resistant human breast cancer cell line MDA-MB-231. Proteomics. 2011;11:3877\u201386. https:\/\/doi.org\/10.1002\/pmic.201000789.","journal-title":"Proteomics"},{"key":"9585_CR66","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.3390\/cancers11122011","volume":"11","author":"S Park","year":"2019","unstructured":"Park S, Kim H, Ji HW, Kim HW, Yun SH, Choi EH, Kim SJ. Cold atmospheric plasma restores Paclitaxel sensitivity to Paclitaxel-Resistant breast Cancer cells by reversing expression of Resistance-Related genes. Cancers. 2019;11:2011. https:\/\/doi.org\/10.3390\/cancers11122011.","journal-title":"Cancers"},{"key":"9585_CR67","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/onc.2015.152","volume":"35","author":"P Khongkow","year":"2016","unstructured":"Khongkow P, Gomes AR, Gong C, Man EPS, Tsang JW-H, Zhao F, Monteiro LJ, Coombes RC, Medema RH, Khoo US. Lam, Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer Paclitaxel resistance. Oncogene. 2016;35:990\u20131002. https:\/\/doi.org\/10.1038\/onc.2015.152.","journal-title":"Oncogene"},{"key":"9585_CR68","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-13-0082","volume":"19","author":"SM Singel","year":"2013","unstructured":"Singel SM, Cornelius C, Batten K, Fasciani G, Wright WE, Lum L, Shay JW. A targeted RNAi screen of the breast Cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in Triple-Negative breast cancer, clin. Cancer Res Off J Am Assoc Cancer Res. 2013;19:2061\u201370. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0082.","journal-title":"Cancer Res Off J Am Assoc Cancer Res"},{"key":"9585_CR69","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S1074-5521(02)00212-0","volume":"9","author":"Z Maliga","year":"2002","unstructured":"Maliga Z, Kapoor TM, Mitchison TJ. Evidence that monastrol is an allosteric inhibitor of the mitotic Kinesin Eg5. Chem Biol. 2002;9:989\u201396. https:\/\/doi.org\/10.1016\/S1074-5521(02)00212-0.","journal-title":"Chem Biol"},{"key":"9585_CR70","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00210-016-1292-9","volume":"389","author":"LA Marques","year":"2016","unstructured":"Marques LA, Semprebon SC, Niwa AM, D\u2019Epiro GFR, Sartori D, de F\u00e1tima \u00c2, Ribeiro LR, Mantovani MS. Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells, Naunyn. Schmiedebergs Arch Pharmacol. 2016;389:1279\u201388. https:\/\/doi.org\/10.1007\/s00210-016-1292-9.","journal-title":"Schmiedebergs Arch Pharmacol"},{"key":"9585_CR71","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3892\/ijo.2018.4485","volume":"53","author":"Y Liu","year":"2018","unstructured":"Liu Y, Dong Y, Zhao L, Su L, Luo J. Circular RNA\u2013MTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4\/Eg5 axis. Int J Oncol. 2018;53:1752\u201362. https:\/\/doi.org\/10.3892\/ijo.2018.4485.","journal-title":"Int J Oncol"},{"key":"9585_CR72","doi-asserted-by":"publisher","first-page":"112025","DOI":"10.1016\/j.biopha.2021.112025","volume":"142","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Khoshbakht T, Bahranian A, Taheri M, Hallajnejad M. CircMTO1: A circular RNA with roles in the carcinogenesis. Biomed Pharmacother. 2021;142:112025. https:\/\/doi.org\/10.1016\/j.biopha.2021.112025.","journal-title":"Biomed Pharmacother"},{"key":"9585_CR73","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1002\/1878-0261.12687","volume":"14","author":"A Singh","year":"2020","unstructured":"Singh A, Denu RA, Wolfe SK, Sperger JM, Schehr J, Witkowsky T, Esbona K, Chappell RJ, Weaver BA, Burkard ME, Lang JM. Centrosome amplification is a frequent event in Circulating tumor cells from subjects with metastatic breast cancer. Mol Oncol. 2020;14:1898\u2013909. https:\/\/doi.org\/10.1002\/1878-0261.12687.","journal-title":"Mol Oncol"},{"key":"9585_CR74","doi-asserted-by":"publisher","first-page":"T47","DOI":"10.1530\/ERC-17-0072","volume":"24","author":"A Ogden","year":"2017","unstructured":"Ogden A, Rida PCG, Aneja R, Amplification C. A suspect in breast Cancer and Racial disparities. Endocr Relat Cancer. 2017;24:T47\u201364. https:\/\/doi.org\/10.1530\/ERC-17-0072.","journal-title":"Endocr Relat Cancer"},{"key":"9585_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00214-7","volume":"5","author":"Q Wu","year":"2020","unstructured":"Wu Q, Li B, Liu L, Sun S, Sun S. Centrosome dysfunction: a link between senescence and tumor immunity, signal transduct. Target Ther. 2020;5:1\u20139. https:\/\/doi.org\/10.1038\/s41392-020-00214-7.","journal-title":"Target Ther"},{"key":"9585_CR76","doi-asserted-by":"publisher","first-page":"112292","DOI":"10.1016\/j.biopha.2021.112292","volume":"144","author":"Y Luan","year":"2021","unstructured":"Luan Y, Li M, Zhao Y, Li Q, Wen J, Gao S, Yang Y. Centrosomal-associated proteins: potential therapeutic targets for solid tumors? Biomed Pharmacother. 2021;144:112292. https:\/\/doi.org\/10.1016\/j.biopha.2021.112292.","journal-title":"Biomed Pharmacother"},{"key":"9585_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2083-x","volume":"16","author":"RA Denu","year":"2016","unstructured":"Denu RA, Zasadil LM, Kanugh C, Laffin J, Weaver BA, Burkard ME. Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer. BMC Cancer. 2016;16:1\u201313. https:\/\/doi.org\/10.1186\/s12885-016-2083-x.","journal-title":"BMC Cancer"},{"key":"9585_CR78","doi-asserted-by":"publisher","unstructured":"Sepulveda G, Antkowiak M, Brust-Mascher I, Mahe K, Ou T, Castro NM, Christensen LN, Cheung L, Jiang X, Yoon D, Huang B, Jao L-E. Co-translational protein targeting facilitates centrosomal recruitment of PCNT during centrosome maturation in vertebrates. eLife. 2018;7. https:\/\/doi.org\/10.7554\/eLife.34959.","DOI":"10.7554\/eLife.34959"},{"key":"9585_CR79","doi-asserted-by":"publisher","unstructured":"Splinter D, Tanenbaum ME, Lindqvist A, Jaarsma D, Flotho A, Yu KL, Grigoriev I, Engelsma D, Haasdijk ED, Keijzer N, Demmers J, Fornerod M, Melchior F, Hoogenraad CC, Medema RH, Akhmanova A. Bicaudal D2, dynein, and Kinesin-1 associate with nuclear pore complexes and regulate centrosome and nuclear positioning during mitotic entry. PLoS Biol. 2010;8. https:\/\/doi.org\/10.1371\/journal.pbio.1000350.","DOI":"10.1371\/journal.pbio.1000350"},{"key":"9585_CR80","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s41556-019-0382-6","volume":"21","author":"S Hata","year":"2019","unstructured":"Hata S, Pastor Peidro A, Panic M, Liu P, Atorino E, Funaya C, J\u00e4kle U, Pereira G, Schiebel E. The balance between KIFC3 and EG5 tetrameric kinesins controls the onset of mitotic spindle assembly. Nat Cell Biol. 2019;21:1138\u201351. https:\/\/doi.org\/10.1038\/s41556-019-0382-6.","journal-title":"Nat Cell Biol"},{"key":"9585_CR81","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1080\/15384101.2016.1195531","volume":"15","author":"S Malik","year":"2016","unstructured":"Malik S, Saito H, Takaoka M, Miki Y, Nakanishi A. BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein. Cell Cycle. 2016;15:2145\u201356. https:\/\/doi.org\/10.1080\/15384101.2016.1195531.","journal-title":"Cell Cycle"},{"key":"9585_CR82","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cub.2017.11.046","volume":"28","author":"S Eibes","year":"2018","unstructured":"Eibes S, Gallis\u00e0-Su\u00f1\u00e9 N, Rosas-Salvans M, Mart\u00ednez-Delgado P, Vernos I, Roig J. Nek9 phosphorylation defines a new role for TPX2 in Eg5-Dependent centrosome separation before nuclear envelope breakdown. Curr Biol CB. 2018;28:121\u2013e1294. https:\/\/doi.org\/10.1016\/j.cub.2017.11.046.","journal-title":"Curr Biol CB"},{"key":"9585_CR83","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/ncb3369","volume":"18","author":"JH van Ree","year":"2016","unstructured":"van Ree JH, Nam H-J, Jeganathan KB, Kanakkanthara A, van Deursen JM. Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes. Nat Cell Biol. 2016;18:814\u201321. https:\/\/doi.org\/10.1038\/ncb3369.","journal-title":"Nat Cell Biol"},{"key":"9585_CR84","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1016\/j.cub.2017.08.018","volume":"27","author":"DN Reinemann","year":"2017","unstructured":"Reinemann DN, Sturgill EG, Das DK, Degen MS, V\u00f6r\u00f6s Z, Hwang W, Ohi R, Lang MJ. Collective force regulation in Anti-parallel microtubule gliding by dimeric Kif15 Kinesin motors. Curr Biol CB. 2017;27:2810\u2013e28206. https:\/\/doi.org\/10.1016\/j.cub.2017.08.018.","journal-title":"Curr Biol CB"},{"key":"9585_CR85","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.cub.2009.08.027","volume":"19","author":"ME Tanenbaum","year":"2009","unstructured":"Tanenbaum ME, Mac\u016frek L, Janssen A, Geers EF, Alvarez-Fern\u00e1ndez M, Medema RH. Kif15 cooperates with Eg5 to promote bipolar spindle assembly. Curr Biol. 2009;19:1703\u201311. https:\/\/doi.org\/10.1016\/j.cub.2009.08.027.","journal-title":"Curr Biol"},{"key":"9585_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms4686","volume":"5","author":"K Drosopoulos","year":"2014","unstructured":"Drosopoulos K, Tang C, Chao WCH, Linardopoulos S. APC\/C is an essential regulator of centrosome clustering. Nat Commun. 2014;5:1\u201313. https:\/\/doi.org\/10.1038\/ncomms4686.","journal-title":"Nat Commun"},{"key":"9585_CR87","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1091\/mbc.11.6.2047","volume":"11","author":"A Young","year":"2000","unstructured":"Young A, Dictenberg JB, Purohit A, Tuft R, Doxsey SJ. Cytoplasmic dynein-mediated assembly of pericentrin and gamma tubulin onto centrosomes. Mol Biol Cell. 2000;11:2047\u201356. https:\/\/doi.org\/10.1091\/mbc.11.6.2047.","journal-title":"Mol Biol Cell"},{"key":"9585_CR88","doi-asserted-by":"publisher","unstructured":"Vitre B, Taulet N, Guesdon A, Douanier A, Dosdane A, Cisneros M, Maurin J, Hettinger S, Anguille C, Taschner M, Lorentzen E, Delaval B. IFT proteins interact with HSET to promote supernumerary centrosome clustering in mitosis. EMBO Rep N\/a. 2020;e49234. https:\/\/doi.org\/10.15252\/embr.201949234.","DOI":"10.15252\/embr.201949234"},{"key":"9585_CR89","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41467-021-21447-2","volume":"12","author":"C Marquis","year":"2021","unstructured":"Marquis C, Fonseca CL, Queen KA, Wood L, Vandal SE, Malaby HLH, Clayton JE, Stumpff J. Chromosomally unstable tumor cells specifically require KIF18A for proliferation. Nat Commun. 2021;12:1213. https:\/\/doi.org\/10.1038\/s41467-021-21447-2.","journal-title":"Nat Commun"},{"key":"9585_CR90","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1091\/mbc.E02-02-0112","volume":"13","author":"M Takahashi","year":"2002","unstructured":"Takahashi M, Yamagiwa A, Nishimura T, Mukai H, Ono Y, Centrosomal Proteins CG-NAP. Kendrin provide microtubule nucleation sites by anchoring \u03b3-Tubulin ring complex. Mol Biol Cell. 2002;13:3235\u201345. https:\/\/doi.org\/10.1091\/mbc.E02-02-0112.","journal-title":"Mol Biol Cell"},{"key":"9585_CR91","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nsmb.2996","volume":"22","author":"S Chowdhury","year":"2015","unstructured":"Chowdhury S, Ketcham SA, Schroer TA, Lander GC. Structural organization of the dynein-dynactin complex bound to microtubules. Nat Struct Mol Biol. 2015;22:345\u20137. https:\/\/doi.org\/10.1038\/nsmb.2996.","journal-title":"Nat Struct Mol Biol"},{"key":"9585_CR92","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.devcel.2010.11.011","volume":"19","author":"ME Tanenbaum","year":"2010","unstructured":"Tanenbaum ME, Medema RH. Mechanisms of centrosome separation and bipolar spindle assembly. Dev Cell. 2010;19:797\u2013806. https:\/\/doi.org\/10.1016\/j.devcel.2010.11.011.","journal-title":"Dev Cell"},{"key":"9585_CR93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.yexcr.2015.02.010","volume":"334","author":"JJ Vicente","year":"2015","unstructured":"Vicente JJ, Wordeman L. Mitosis, microtubule dynamics and the evolution of kinesins, exp. Cell Res. 2015;334:61\u20139. https:\/\/doi.org\/10.1016\/j.yexcr.2015.02.010.","journal-title":"Cell Res"},{"key":"9585_CR94","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00412-016-0607-4","volume":"126","author":"RGHP van Heesbeen","year":"2017","unstructured":"van Heesbeen RGHP, Raaijmakers JA, Tanenbaum ME, Halim VA, Lelieveld D, Lieftink C, Heck AJR, Egan DA, Medema RH. Aurora A, MCAK, and Kif18b promote Eg5-independent spindle formation. Chromosoma. 2017;126:473\u201386. https:\/\/doi.org\/10.1007\/s00412-016-0607-4.","journal-title":"Chromosoma"}],"container-title":["Journal of Mammary Gland Biology and Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-025-09585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10911-025-09585-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-025-09585-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:45:48Z","timestamp":1758883548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10911-025-09585-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9585"],"URL":"https:\/\/doi.org\/10.1007\/s10911-025-09585-5","relation":{},"ISSN":["1083-3021","1573-7039"],"issn-type":[{"value":"1083-3021","type":"print"},{"value":"1573-7039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}